De Simoni, O.; Scarpa, M.; Soldà , C.; Bergamo, F.; Lonardi, S.; Fantin, A.; Pilati, P.; Gruppo, M.
Could Total Neoadjuvant Therapy Followed by Surgical Resection Be the New Standard of Care in Pancreatic Cancer? A Systematic Review and Meta-Analysis. J. Clin. Med. 2022, 11, 812.
https://doi.org/10.3390/jcm11030812
AMA Style
De Simoni O, Scarpa M, Soldà C, Bergamo F, Lonardi S, Fantin A, Pilati P, Gruppo M.
Could Total Neoadjuvant Therapy Followed by Surgical Resection Be the New Standard of Care in Pancreatic Cancer? A Systematic Review and Meta-Analysis. Journal of Clinical Medicine. 2022; 11(3):812.
https://doi.org/10.3390/jcm11030812
Chicago/Turabian Style
De Simoni, Ottavia, Marco Scarpa, Caterina Soldà , Francesca Bergamo, Sara Lonardi, Alberto Fantin, Pierluigi Pilati, and Mario Gruppo.
2022. "Could Total Neoadjuvant Therapy Followed by Surgical Resection Be the New Standard of Care in Pancreatic Cancer? A Systematic Review and Meta-Analysis" Journal of Clinical Medicine 11, no. 3: 812.
https://doi.org/10.3390/jcm11030812
APA Style
De Simoni, O., Scarpa, M., Soldà , C., Bergamo, F., Lonardi, S., Fantin, A., Pilati, P., & Gruppo, M.
(2022). Could Total Neoadjuvant Therapy Followed by Surgical Resection Be the New Standard of Care in Pancreatic Cancer? A Systematic Review and Meta-Analysis. Journal of Clinical Medicine, 11(3), 812.
https://doi.org/10.3390/jcm11030812